Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptidesShu-Ting Hong, Yu‐Li Lo|Journal of Nanobiotechnology|2019Cited by 60
Gene-editing by CRISPR–Cas9 in combination with anthracycline therapy <i>via</i> tumor microenvironment-switchable, EGFR-targeted, and nucleus-directed nanoparticles for head and neck cancer suppressionChen-Shen Wang, Yu‐Li Lo|Nanoscale Horizons|2021Cited by 57
Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cellsGuan-Liang Lin, Yu‐Li Lo|PLoS ONE|2017Cited by 47
Galectin-3 Silencing Inhibits Epirubicin-Induced ATP Binding Cassette Transporters and Activates the Mitochondrial Apoptosis Pathway via β-Catenin/GSK-3β Modulation in Colorectal CarcinomaYung‐Kuo Lee, Yu‐Li Lo|PLoS ONE|2013Cited by 43
Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2&ndash;3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cellsVivian Juang, Yu‐Li Lo|International Journal of Nanomedicine|2016Cited by 40